Skip to main content

Teladoc Health Stock Drops After Reporting Wider Than Expected Q2 Net Loss; Analysts Lower Price Target

Teladoc Health Inc posted a wider than expected net loss in Q2 of $133.8 million, or $(0.86) a share, compared with $25.7 million or $(0.34) posted a year ago primarily due to expenses related to the large-scale acquisition of Livongo Health.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.